Partnerships
The CRC Program is uniquely positioned as the only funding mechanism in Australia capable of providing the scale and duration necessary to drive transformational change across entire industry sectors. It enhances our international competitiveness and creates new employment opportunities.
The program aims to foster large-scale research collaborations between industry and academia, addressing critical challenges to deliver substantial economic, environmental, and social benefits to Australian industries.
Government funding for each CRC typically ranges from $20M to $55M, which is matched by participant cash contributions. In addition to these cash investments, participants also provide significant in-kind support to ensure the success of the program.
Be at the forefront of advancements in AI innovation for drug discovery and development.
Access research outcomes critical to your business at a fraction of the cost by leveraging Commonwealth funding.
Collaborate with Australia’s leading researchers focused on solving the most pressing challenges in drug discovery and development.
Gain preferential access to intellectual property (IP) developed through the CRC to enhance your organisation’s competitiveness.
Claim tax rebate on qualifying contributions under the R&D Tax Incentive program.
Connect with a network of pioneering organisations driving innovation in AI and drug discovery.
Influence skills development and training programs to create a future-ready workforce.
Leverage standout postgraduate and PhD students to support your organisation through collaborative projects and as potential future hires.
Your participation & benefits
The AIEDD CRC offers flexible participation options tailored to align with your strategic goals, resources, and desired level of involvement. Whether through cash contributions and/or in-kind support, partners can choose from various tiers of engagement, each offering proportional benefits that reflect their commitment. This flexible model ensures all participants can actively contribute to and benefit from this transformative initiative, driving innovation in AI enhanced drug discovery.